(Q47957510)

7 February 2018

title

Serum cholesterol levels are underevaluated and undertreated (English)

1 reference

7 February 2018

author

Martha J Radford

3

1 reference

7 February 2018

author name string

Danias PG

1

1 reference

7 February 2018

O'Mahony S

2

1 reference

7 February 2018

Korman L

4

1 reference

7 February 2018

Silverman DI

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

7 February 2018

American Journal of Cardiology

published in

1 reference

7 February 2018

volume

81

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

1353-1356

1 reference

7 February 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Suboptimal outcome of management of metabolic cardiovascular risk factors in Hispanic patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

A comparison of self-report and chart audit in studying resident physician assessment of cardiac risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900167-2

10.1016/S0002-9149(98)00167-2

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018